250 related articles for article (PubMed ID: 23555254)
1. Digoxin suppresses HIV-1 replication by altering viral RNA processing.
Wong RW; Balachandran A; Ostrowski MA; Cochrane A
PLoS Pathog; 2013 Mar; 9(3):e1003241. PubMed ID: 23555254
[TBL] [Abstract][Full Text] [Related]
2. Cardiac glycoside/aglycones inhibit HIV-1 gene expression by a mechanism requiring MEK1/2-ERK1/2 signaling.
Wong RW; Lingwood CA; Ostrowski MA; Cabral T; Cochrane A
Sci Rep; 2018 Jan; 8(1):850. PubMed ID: 29339801
[TBL] [Abstract][Full Text] [Related]
3. Identification of small molecule modulators of HIV-1 Tat and Rev protein accumulation.
Balachandran A; Wong R; Stoilov P; Pan S; Blencowe B; Cheung P; Harrigan PR; Cochrane A
Retrovirology; 2017 Jan; 14(1):7. PubMed ID: 28122580
[TBL] [Abstract][Full Text] [Related]
4. The Thiazole-5-Carboxamide GPS491 Inhibits HIV-1, Adenovirus, and Coronavirus Replication by Altering RNA Processing/Accumulation.
Dahal S; Cheng R; Cheung PK; Been T; Malty R; Geng M; Manianis S; Shkreta L; Jahanshahi S; Toutant J; Chan R; Park S; Brockman MA; Babu M; Mubareka S; Mossman K; Banerjee A; Gray-Owen S; Brown M; Houry WA; Chabot B; Grierson D; Cochrane A
Viruses; 2021 Dec; 14(1):. PubMed ID: 35062264
[TBL] [Abstract][Full Text] [Related]
5. Characterization of novel inhibitors of HIV-1 replication that function via alteration of viral RNA processing and rev function.
Wong RW; Balachandran A; Haaland M; Stoilov P; Cochrane A
Nucleic Acids Res; 2013 Nov; 41(20):9471-83. PubMed ID: 23945945
[TBL] [Abstract][Full Text] [Related]
6. Suppression of Adenovirus Replication by Cardiotonic Steroids.
Grosso F; Stoilov P; Lingwood C; Brown M; Cochrane A
J Virol; 2017 Feb; 91(3):. PubMed ID: 27881644
[TBL] [Abstract][Full Text] [Related]
7. An activator of G protein-coupled receptor and MEK1/2-ERK1/2 signaling inhibits HIV-1 replication by altering viral RNA processing.
Wong RW; Balachandran A; Cheung PK; Cheng R; Pan Q; Stoilov P; Harrigan PR; Blencowe BJ; Branch DR; Cochrane A
PLoS Pathog; 2020 Feb; 16(2):e1008307. PubMed ID: 32069328
[TBL] [Abstract][Full Text] [Related]
8. Differential effect of CLK SR Kinases on HIV-1 gene expression: potential novel targets for therapy.
Wong R; Balachandran A; Mao AY; Dobson W; Gray-Owen S; Cochrane A
Retrovirology; 2011 Jun; 8():47. PubMed ID: 21682887
[TBL] [Abstract][Full Text] [Related]
9. Differential Effects of Tra2ß Isoforms on HIV-1 RNA Processing and Expression.
Platt C; Calimano M; Nemet J; Bubenik J; Cochrane A
PLoS One; 2015; 10(5):e0125315. PubMed ID: 25970345
[TBL] [Abstract][Full Text] [Related]
10. HIV Rev-dependent binding of SF2/ASF to the Rev response element: possible role in Rev-mediated inhibition of HIV RNA splicing.
Powell DM; Amaral MC; Wu JY; Maniatis T; Greene WC
Proc Natl Acad Sci U S A; 1997 Feb; 94(3):973-8. PubMed ID: 9023367
[TBL] [Abstract][Full Text] [Related]
11. Antagonism of the Sodium-Potassium ATPase Impairs Chikungunya Virus Infection.
Ashbrook AW; Lentscher AJ; Zamora PF; Silva LA; May NA; Bauer JA; Morrison TE; Dermody TS
mBio; 2016 May; 7(3):. PubMed ID: 27222471
[TBL] [Abstract][Full Text] [Related]
12. The herpes simplex virus 1 Us11 protein cooperates with suboptimal amounts of human immunodeficiency virus type 1 (HIV-1) Rev protein to rescue HIV-1 production.
Duc Dodon M; Mikaélian I; Sergeant A; Gazzolo L
Virology; 2000 Apr; 270(1):43-53. PubMed ID: 10772978
[TBL] [Abstract][Full Text] [Related]
13. Bioavailable inhibitors of HIV-1 RNA biogenesis identified through a Rev-based screen.
Prado S; Beltrán M; Coiras M; Bedoya LM; Alcamí J; Gallego J
Biochem Pharmacol; 2016 May; 107():14-28. PubMed ID: 26896646
[TBL] [Abstract][Full Text] [Related]
14. Influence of L-lysine amino acid on the HIV-1 RNA replication in vitro.
Butorov EV
Antivir Chem Chemother; 2015 Feb; 24(1):39-46. PubMed ID: 26149265
[TBL] [Abstract][Full Text] [Related]
15. Small molecules that selectively block RNA binding of HIV-1 Rev protein inhibit Rev function and viral production.
Zapp ML; Stern S; Green MR
Cell; 1993 Sep; 74(6):969-78. PubMed ID: 8402886
[TBL] [Abstract][Full Text] [Related]
16. SRSF1 RNA Recognition Motifs Are Strong Inhibitors of HIV-1 Replication.
Paz S; Lu ML; Takata H; Trautmann L; Caputi M
J Virol; 2015 Jun; 89(12):6275-86. PubMed ID: 25855733
[TBL] [Abstract][Full Text] [Related]
17. Utilization of host SR protein kinases and RNA-splicing machinery during viral replication.
Fukuhara T; Hosoya T; Shimizu S; Sumi K; Oshiro T; Yoshinaka Y; Suzuki M; Yamamoto N; Herzenberg LA; Herzenberg LA; Hagiwara M
Proc Natl Acad Sci U S A; 2006 Jul; 103(30):11329-33. PubMed ID: 16840555
[TBL] [Abstract][Full Text] [Related]
18. Mathematical model of the Tat-Rev regulation of HIV-1 replication in an activated cell predicts the existence of oscillatory dynamics in the synthesis of viral components.
Likhoshvai VA; Khlebodarova TM; Bazhan SI; Gainova IA; Chereshnev VA; Bocharov GA
BMC Genomics; 2014; 15 Suppl 12(Suppl 12):S1. PubMed ID: 25564443
[TBL] [Abstract][Full Text] [Related]
19. hnRNP E1 and E2 have distinct roles in modulating HIV-1 gene expression.
Woolaway K; Asai K; Emili A; Cochrane A
Retrovirology; 2007 Apr; 4():28. PubMed ID: 17451601
[TBL] [Abstract][Full Text] [Related]
20. Control of the papillomavirus early-to-late switch by differentially expressed SRp20.
Jia R; Liu X; Tao M; Kruhlak M; Guo M; Meyers C; Baker CC; Zheng ZM
J Virol; 2009 Jan; 83(1):167-80. PubMed ID: 18945760
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
